DexCom
DXCM
YETI Holdings
YETI
New Fortress Energy
NFE
Dorian LPG
LPG
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.74%324.66B | 0.22%87.38B | -0.47%78.48B | 4.10%83.34B | -0.97%75.46B | 15.49%322.28B | 14.46%87.18B | 11.56%78.85B | 15.19%80.06B | 21.50%76.2B |
Operating revenue | 0.74%324.66B | 0.22%87.38B | -0.47%78.48B | 4.10%83.34B | -0.97%75.46B | 15.49%322.28B | 14.46%87.18B | 11.56%78.85B | 15.19%80.06B | 21.50%76.2B |
Cost of revenue | 1.49%265.18B | -0.33%70.29B | -0.02%65.42B | 5.01%67.56B | 1.49%61.92B | 15.18%261.3B | 11.77%70.52B | 12.81%65.44B | 16.94%64.34B | 20.22%61.01B |
Gross profit | -2.48%59.47B | 2.57%17.09B | -2.62%13.06B | 0.38%15.78B | -10.83%13.55B | 16.87%60.99B | 27.49%16.66B | 5.87%13.41B | 8.57%15.72B | 26.95%15.19B |
Operating expense | 14.06%40.32B | 49.19%10.84B | 19.85%10.2B | 1.93%10.32B | -5.18%8.96B | 4.04%35.35B | -39.15%7.27B | 1.27%8.51B | 1.31%10.12B | 159.60%9.45B |
Selling and administrative expenses | 2.93%35.07B | 3.22%9.7B | -2.37%8.25B | 6.31%8.66B | 4.75%8.46B | 8.19%34.07B | 5.42%9.4B | 6.28%8.45B | 8.00%8.15B | 14.00%8.08B |
-Selling and marketing expense | 4.57%22.32B | 5.20%6.31B | 3.35%5.5B | 4.22%5.41B | 5.52%5.1B | 7.59%21.35B | 1.25%6B | 9.97%5.32B | 8.99%5.19B | 12.07%4.84B |
-General and administrative expense | 0.20%12.75B | -0.27%3.39B | -12.07%2.75B | 9.97%3.26B | 3.61%3.36B | 9.21%12.73B | 13.69%3.4B | 0.55%3.13B | 6.32%2.96B | 17.00%3.24B |
Other operating expenses | 86.04%10.08B | 197.07%5.97B | 2,953.13%1.95B | -16.18%1.65B | -63.72%497M | -17.10%5.42B | -71.59%2.01B | -85.96%64M | -19.35%1.97B | 139.76%1.37B |
Operating profit | -25.29%19.15B | -33.49%6.25B | -41.70%2.85B | -2.43%5.46B | -20.14%4.59B | 40.80%25.64B | 732.15%9.4B | 14.93%4.9B | 24.72%5.6B | -31.02%5.75B |
Net non-operating interest income expense | -18.21%-1.2B | 49.32%-335M | -3,712.50%-915M | 43.23%-285M | 95.32%334M | -210.55%-1.02B | -123.54%-661M | 98.83%-24M | -356.12%-502M | 517.07%171M |
Non-operating interest income | -9.07%2.42B | ---- | ---- | ---- | ---- | 3.71%2.66B | ---- | ---- | ---- | ---- |
Non-operating interest expense | -5.25%3.45B | ---- | ---- | ---- | ---- | 121.09%3.64B | ---- | ---- | ---- | ---- |
Total other finance cost | 385.71%170M | ---- | ---- | ---- | ---- | 1,266.67%35M | ---- | ---- | ---- | ---- |
Other net income (expense) | ||||||||||
Special income (charges) | -80.00%36M | ---- | ---- | ---- | ---- | -55.33%180M | ---- | ---- | ---- | ---- |
-Less:Other special charges | 80.00%-36M | ---- | ---- | ---- | ---- | 55.33%-180M | ---- | ---- | ---- | ---- |
Income before tax | -27.24%16.81B | -20.67%4.28B | -59.39%2.36B | -8.45%4.99B | -19.71%5.18B | 4.66%23.1B | 6.32%5.4B | 97.51%5.8B | 5.97%5.45B | -27.62%6.45B |
Income tax | -15.77%4.41B | 98.52%804M | -46.39%780M | -18.13%1.36B | -14.63%1.47B | -15.76%5.24B | -79.89%405M | 81.20%1.46B | 34.88%1.66B | -20.71%1.72B |
Net income | -30.61%12.39B | -30.36%3.48B | -63.75%1.58B | -4.22%3.63B | -21.56%3.71B | 12.67%17.86B | 63.01%4.99B | 103.61%4.35B | -3.09%3.79B | -29.85%4.73B |
Net income continuous Operations | -30.61%12.4B | -30.34%3.48B | -63.74%1.58B | -4.22%3.63B | -21.56%3.71B | 12.67%17.86B | 62.99%4.99B | 103.66%4.35B | -3.09%3.79B | -29.85%4.73B |
Minority interest income | -21.52%1.04B | -17.32%191M | -33.12%210M | -10.20%361M | -26.44%281M | 236.46%1.33B | -24.76%231M | 1,156.00%314M | 1,647.83%402M | 855.00%382M |
Net income attributable to the parent company | -31.34%11.35B | -31.00%3.29B | -66.13%1.37B | -3.51%3.27B | -21.14%3.43B | 6.95%16.53B | 72.79%4.76B | 91.14%4.03B | -12.86%3.39B | -35.13%4.35B |
Preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other preferred stock dividends | 7.69%630M | -4.91%155M | 6.94%154M | 13.67%158M | 17.27%163M | 1.56%585M | 11.64%163M | -4.64%144M | -7.33%139M | 7.75%139M |
Net income attributable to common stockholders | -32.77%10.72B | -31.92%3.13B | -68.84%1.21B | -4.25%3.11B | -22.40%3.27B | 7.16%15.95B | 76.21%4.6B | 98.52%3.89B | -13.08%3.25B | -35.98%4.21B |
Basic earnings per share | -32.81%21.36 | -32.03%6.24 | -68.81%2.42 | -4.17%6.21 | -22.46%6.49 | 7.18%31.79 | 76.20%9.18 | 98.47%7.76 | -13.14%6.48 | -36.06%8.37 |
Diluted earnings per share | -32.81%21.36 | -32.03%6.24 | -68.81%2.42 | -4.17%6.21 | -22.46%6.49 | 7.18%31.79 | 76.20%9.18 | 98.47%7.76 | -13.14%6.48 | -36.06%8.37 |
Dividend per share | 3.42%9.06 | 0 | 0 | 3.42%9.06 | 0 | 15.87%8.76 | 0 | 0 | 15.87%8.76 | 0 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |